Remdesivir's MOA is based on disruption of viral r
Post# of 148336
(Total Views: 530)
Posted On: 02/22/2022 10:57:59 AM
Re: Buddyboy20 #118825
Remdesivir's MOA is based on disruption of viral replication and yet the viral load drop for the trial used for approval has never been released. Instead of chastising Cytodyn about something that has a basis for it's claims maybe they should look into that.
(10)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼